Global Quetiapine Fumarate Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032
Description
Market Overview
According to DIResearch's in-depth investigation and research, the global Quetiapine Fumarate market size will reach 159.70 Million USD in 2025 and is projected to reach 130.53 Million USD by 2032, with a CAGR of -2.84% (2025-2032). Notably, the China Quetiapine Fumarate market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Quetiapine fumarate is a medication belonging to the class of atypical antipsychotics. It is commonly prescribed under the brand name Seroquel. Quetiapine is used to treat various psychiatric disorders, including schizophrenia, bipolar disorder, and major depressive disorder. The drug works by affecting the balance of neurotransmitters, particularly serotonin and dopamine, in the brain. It has antagonistic effects on certain receptors, which contribute to its therapeutic actions. Quetiapine is known for its efficacy in alleviating symptoms such as hallucinations, delusions, mood swings, and disturbances in thought patterns associated with psychiatric conditions. Additionally, it is sometimes used as an adjunct treatment for certain anxiety disorders. As with any medication, its use involves considerations of potential side effects, and patients are typically prescribed quetiapine under the supervision and guidance of healthcare professionals.
The major global manufacturers of Quetiapine Fumarate include AstraZeneca, Intas, TAPI, Accord, Hexal, Dr.Reddy's, Lupin, Sun Pharmaceutical, Hunan Dongting Pharm, SuZhou NO.4 Phamaceutical Factory, Fuan Pharmaceutical, Zhejiang Supor Pharmaceuticals, Zhejiang Huahai Pharmaceutical, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Quetiapine Fumarate. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Quetiapine Fumarate market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Quetiapine Fumarate market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Quetiapine Fumarate industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Quetiapine Fumarate Include:
AstraZeneca
Intas
TAPI
Accord
Hexal
Dr.Reddy's
Lupin
Sun Pharmaceutical
Hunan Dongting Pharm
SuZhou NO.4 Phamaceutical Factory
Fuan Pharmaceutical
Zhejiang Supor Pharmaceuticals
Zhejiang Huahai Pharmaceutical
Quetiapine Fumarate Product Segment Include:
Immediate Release Tablets
Extended Release Tablets
Quetiapine Fumarate Product Application Include:
Schizophrenia
Bipolar Disorder
Major Depressive Disorder (MDD)
Generalized Anxiety Disorder (GAD)
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Quetiapine Fumarate Industry PESTEL Analysis
Chapter 3: Global Quetiapine Fumarate Industry Porter's Five Forces Analysis
Chapter 4: Global Quetiapine Fumarate Major Regional Market Size (Sales, Revenue, Price) and Forecast Analysis
Chapter 5: Global Quetiapine Fumarate Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 6: Global Quetiapine Fumarate Sales, Revenue, Price and Forecast by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 8: Industrial Chain Analysis, Quetiapine Fumarate Different Application Market Analysis (Sales and Revenue), Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
According to DIResearch's in-depth investigation and research, the global Quetiapine Fumarate market size will reach 159.70 Million USD in 2025 and is projected to reach 130.53 Million USD by 2032, with a CAGR of -2.84% (2025-2032). Notably, the China Quetiapine Fumarate market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Quetiapine fumarate is a medication belonging to the class of atypical antipsychotics. It is commonly prescribed under the brand name Seroquel. Quetiapine is used to treat various psychiatric disorders, including schizophrenia, bipolar disorder, and major depressive disorder. The drug works by affecting the balance of neurotransmitters, particularly serotonin and dopamine, in the brain. It has antagonistic effects on certain receptors, which contribute to its therapeutic actions. Quetiapine is known for its efficacy in alleviating symptoms such as hallucinations, delusions, mood swings, and disturbances in thought patterns associated with psychiatric conditions. Additionally, it is sometimes used as an adjunct treatment for certain anxiety disorders. As with any medication, its use involves considerations of potential side effects, and patients are typically prescribed quetiapine under the supervision and guidance of healthcare professionals.
The major global manufacturers of Quetiapine Fumarate include AstraZeneca, Intas, TAPI, Accord, Hexal, Dr.Reddy's, Lupin, Sun Pharmaceutical, Hunan Dongting Pharm, SuZhou NO.4 Phamaceutical Factory, Fuan Pharmaceutical, Zhejiang Supor Pharmaceuticals, Zhejiang Huahai Pharmaceutical, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Quetiapine Fumarate. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Quetiapine Fumarate market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Quetiapine Fumarate market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Quetiapine Fumarate industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Quetiapine Fumarate Include:
AstraZeneca
Intas
TAPI
Accord
Hexal
Dr.Reddy's
Lupin
Sun Pharmaceutical
Hunan Dongting Pharm
SuZhou NO.4 Phamaceutical Factory
Fuan Pharmaceutical
Zhejiang Supor Pharmaceuticals
Zhejiang Huahai Pharmaceutical
Quetiapine Fumarate Product Segment Include:
Immediate Release Tablets
Extended Release Tablets
Quetiapine Fumarate Product Application Include:
Schizophrenia
Bipolar Disorder
Major Depressive Disorder (MDD)
Generalized Anxiety Disorder (GAD)
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Quetiapine Fumarate Industry PESTEL Analysis
Chapter 3: Global Quetiapine Fumarate Industry Porter's Five Forces Analysis
Chapter 4: Global Quetiapine Fumarate Major Regional Market Size (Sales, Revenue, Price) and Forecast Analysis
Chapter 5: Global Quetiapine Fumarate Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 6: Global Quetiapine Fumarate Sales, Revenue, Price and Forecast by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 8: Industrial Chain Analysis, Quetiapine Fumarate Different Application Market Analysis (Sales and Revenue), Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
Table of Contents
165 Pages
- 1 Quetiapine Fumarate Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Quetiapine Fumarate Product by Type
- 1.2.1 Immediate Release Tablets
- 1.2.2 Extended Release Tablets
- 1.3 Quetiapine Fumarate Product by Application
- 1.3.1 Schizophrenia
- 1.3.2 Bipolar Disorder
- 1.3.3 Major Depressive Disorder (MDD)
- 1.3.4 Generalized Anxiety Disorder (GAD)
- 1.4 Global Quetiapine Fumarate Market Revenue and Sales Analysis
- 1.4.1 Global Quetiapine Fumarate Revenue Market Size Analysis (2020-2032)
- 1.4.2 Global Quetiapine Fumarate Sales Market Size Analysis (2020-2032)
- 1.4.3 Global Quetiapine Fumarate Market Sales Price Trend Analysis (2020-2032)
- 1.5 Quetiapine Fumarate Market Development Status and Trends
- 1.5.1 Quetiapine Fumarate Industry Development Status Analysis
- 1.5.2 Quetiapine Fumarate Industry Development Trends Analysis
- 2 Quetiapine Fumarate Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Quetiapine Fumarate Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Quetiapine Fumarate Market Analysis by Country
- 4.1 Global Quetiapine Fumarate Market Size Analysis by Country: 2024 VS 2025 VS 2032
- 4.1.1 Global Quetiapine Fumarate Revenue and Market Share by Country (2020-2025)
- 4.1.2 Global Quetiapine Fumarate Revenue and Market Share Forecast by Country (2026-2032)
- 4.2 Global Quetiapine Fumarate Sales Analysis by Country: 2024 VS 2025 VS 2032
- 4.2.1 Global Quetiapine Fumarate Sales and Market Share by Country (2020-2025)
- 4.2.2 Global Quetiapine Fumarate Sales and Market Share Forecast by Country (2026-2032)
- 4.3 United States Quetiapine Fumarate Market Sales, Revenue and Growth Rate (2020-2032)
- 4.4 Germany Quetiapine Fumarate Market Sales, Revenue and Growth Rate (2020-2032)
- 4.5 Japan Quetiapine Fumarate Market Sales, Revenue and Growth Rate (2020-2032)
- 4.6 China Quetiapine Fumarate Market Sales, Revenue and Growth Rate (2020-2032)
- 4.7 France Quetiapine Fumarate Market Sales, Revenue and Growth Rate (2020-2032)
- 4.8 U.K. Quetiapine Fumarate Market Sales, Revenue and Growth Rate (2020-2032)
- 4.9 South Korea Quetiapine Fumarate Market Sales, Revenue and Growth Rate (2020-2032)
- 4.10 Canada Quetiapine Fumarate Market Sales, Revenue and Growth Rate (2020-2032)
- 4.11 Italy Quetiapine Fumarate Market Sales, Revenue and Growth Rate (2020-2032)
- 4.12 Russia Quetiapine Fumarate Market Sales, Revenue and Growth Rate (2020-2032)
- 4.13 Mexico Quetiapine Fumarate Market Sales, Revenue and Growth Rate (2020-2032)
- 4.14 Brazil Quetiapine Fumarate Market Sales, Revenue and Growth Rate (2020-2032)
- 4.15 India Quetiapine Fumarate Market Sales, Revenue and Growth Rate (2020-2032)
- 4.16 Vietnam Quetiapine Fumarate Market Sales, Revenue and Growth Rate (2020-2032)
- 4.17 Thailand Quetiapine Fumarate Market Sales, Revenue and Growth Rate (2020-2032)
- 4.18 South Africa Quetiapine Fumarate Market Sales, Revenue and Growth Rate (2020-2032)
- 5 Competition by Manufacturers
- 5.1 Global Quetiapine Fumarate Market Sales, Revenue and Sales Price by Key Manufacturers (2021-2025)
- 5.1.1 Global Quetiapine Fumarate Market Sales by Key Manufacturers (2021-2025)
- 5.1.2 Global Quetiapine Fumarate Market Revenue by Key Manufacturers (2021-2025)
- 5.1.3 Global Quetiapine Fumarate Average Sales Price by Manufacturers (2021-2025)
- 5.2 Quetiapine Fumarate Competitive Landscape Analysis and Market Dynamic
- 5.2.1 Quetiapine Fumarate Competitive Landscape Analysis
- 5.2.2 Global Key Manufacturers Headquarter and Key Area Sales
- 5.2.3 Market Dynamic
- 6 Quetiapine Fumarate Market Analysis by Type
- 6.1 Global Quetiapine Fumarate Market Revenue Analysis by Type
- 6.1.1 Global Quetiapine Fumarate Market Size Analysis by Type: 2024 & 2025 & 2032
- 6.1.2 Global Quetiapine Fumarate Revenue and Forecast Analysis by Type (2020-2032)
- 6.2 Global Quetiapine Fumarate Market Sales and Forecast Analysis by Type (2020-2032)
- 6.3 Global Quetiapine Fumarate Sales Price Trend Analysis by Type (2020-2032)
- 7 Key Companies Analysis
- 7.1 AstraZeneca
- 7.1.1 AstraZeneca Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.1.2 AstraZeneca Quetiapine Fumarate Product Portfolio
- 7.1.3 AstraZeneca Quetiapine Fumarate Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.2 Intas
- 7.2.1 Intas Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.2.2 Intas Quetiapine Fumarate Product Portfolio
- 7.2.3 Intas Quetiapine Fumarate Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.3 TAPI
- 7.3.1 TAPI Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.3.2 TAPI Quetiapine Fumarate Product Portfolio
- 7.3.3 TAPI Quetiapine Fumarate Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.4 Accord
- 7.4.1 Accord Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.4.2 Accord Quetiapine Fumarate Product Portfolio
- 7.4.3 Accord Quetiapine Fumarate Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.5 Hexal
- 7.5.1 Hexal Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.5.2 Hexal Quetiapine Fumarate Product Portfolio
- 7.5.3 Hexal Quetiapine Fumarate Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.6 Dr.Reddy＇s
- 7.6.1 Dr.Reddy＇s Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.6.2 Dr.Reddy＇s Quetiapine Fumarate Product Portfolio
- 7.6.3 Dr.Reddy＇s Quetiapine Fumarate Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.7 Lupin
- 7.7.1 Lupin Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.7.2 Lupin Quetiapine Fumarate Product Portfolio
- 7.7.3 Lupin Quetiapine Fumarate Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.8 Sun Pharmaceutical
- 7.8.1 Sun Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.8.2 Sun Pharmaceutical Quetiapine Fumarate Product Portfolio
- 7.8.3 Sun Pharmaceutical Quetiapine Fumarate Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.9 Hunan Dongting Pharm
- 7.9.1 Hunan Dongting Pharm Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.9.2 Hunan Dongting Pharm Quetiapine Fumarate Product Portfolio
- 7.9.3 Hunan Dongting Pharm Quetiapine Fumarate Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.10 SuZhou NO.4 Phamaceutical Factory
- 7.10.1 SuZhou NO.4 Phamaceutical Factory Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.10.2 SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Product Portfolio
- 7.10.3 SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.11 Fuan Pharmaceutical
- 7.11.1 Fuan Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.11.2 Fuan Pharmaceutical Quetiapine Fumarate Product Portfolio
- 7.11.3 Fuan Pharmaceutical Quetiapine Fumarate Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.12 Zhejiang Supor Pharmaceuticals
- 7.12.1 Zhejiang Supor Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.12.2 Zhejiang Supor Pharmaceuticals Quetiapine Fumarate Product Portfolio
- 7.12.3 Zhejiang Supor Pharmaceuticals Quetiapine Fumarate Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.13 Zhejiang Huahai Pharmaceutical
- 7.13.1 Zhejiang Huahai Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.13.2 Zhejiang Huahai Pharmaceutical Quetiapine Fumarate Product Portfolio
- 7.13.3 Zhejiang Huahai Pharmaceutical Quetiapine Fumarate Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 8 Industry Chain Analysis
- 8.1 Quetiapine Fumarate Industry Chain Analysis
- 8.2 Quetiapine Fumarate Industry Upstream Supply Analysis
- 8.2.1 Upstream Key Raw Material Supply Analysis
- 8.2.2 Raw Material Suppliers and Contact Information
- 8.3 Quetiapine Fumarate Product Downstream Application Analysis
- 8.3.1 Global Quetiapine Fumarate Revenue Market Size by Application: 2024 & 2025 & 2032
- 8.3.2 Global Quetiapine Fumarate Revenue and Forecast Analysis by Application (2020-2032)
- 8.3.3 Global Quetiapine Fumarate Sales and Forecast Analysis by Application (2020-2032)
- 8.4 Quetiapine Fumarate Typical Downstream Customers
- 8.5 Quetiapine Fumarate Sales Channel Analysis
- 9 Research Findings and Conclusion
- 10 Methodology and Data Source
- 10.1 Methodology/Research Approach
- 10.2 Research Scope
- 10.3 Benchmarks and Assumptions
- 10.4 Date Source
- 10.4.1 Primary Sources
- 10.4.2 Secondary Sources
- 10.5 Data Cross Validation
- 10.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
